The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function

被引:34
作者
Chan, FKM [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1136/ard.59.suppl_1.i50
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Signalling by the tumour necrosis factor receptors (TNFR) is thought to be mediated by the binding of the trimeric Ligand TNF to three monomeric subunits of the receptor. This Ligand induced trimerisation model of TNFR signalling is mainly supported by crystallographic data of the p60 TNFR-1 and TNF beta complex in which the trimeric Ligand interdigitates between the individual receptor chains and prevents the receptor subunits from interacting with each other. Recently, a domain NH, terminal to the ligand binding domain in the extracellular region of p60 TNFR-1, p80 TNFR-2 and Fas was identified that mediates receptor self association before Ligand binding. This pre-ligand binding assembly domain or PLAD is critical for assembly of functional receptor complexes on the cell surface and may provide a potential target in the design of future novel therapeutics against diseases mediated by members of the TNFR family of receptors.
引用
收藏
页码:50 / 53
页数:4
相关论文
共 44 条
  • [1] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
    BANNER, DW
    DARCY, A
    JANES, W
    GENTZ, R
    SCHOENFELD, HJ
    BROGER, C
    LOETSCHER, H
    LESSLAUER, W
    [J]. CELL, 1993, 73 (03) : 431 - 445
  • [2] SELF-ASSOCIATION OF THE DEATH DOMAINS OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR AND FAS/APO1 PROMPTS SIGNALING FOR TNF AND FAS/APO1 EFFECTS
    BOLDIN, MP
    METT, IL
    VARFOLOMEEV, EE
    CHUMAKOV, I
    SHEMERAVNI, Y
    CAMONIS, JH
    WALLACH, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) : 387 - 391
  • [3] The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases
    Centola, M
    Aksentijevich, I
    Kastner, DL
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (10) : 1581 - 1588
  • [4] Chan FKM, 2000, EUR J IMMUNOL, V30, P652
  • [5] CHAN FKM, 2000, SICNECE, V288, P2531
  • [6] MAPPING THE DOMAIN(S) CRITICAL FOR THE BINDING OF HUMAN TUMOR-NECROSIS-FACTOR-ALPHA TO ITS 2 RECEPTORS
    CHEN, PCH
    DUBOIS, GC
    CHEN, MJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) : 2874 - 2878
  • [7] CHARACTERIZATION OF LIGAND-BINDING BY THE HUMAN P55 TUMOR-NECROSIS-FACTOR RECEPTOR - INVOLVEMENT OF INDIVIDUAL CYSTEINE-RICH REPEATS
    CORCORAN, AE
    BARRETT, K
    TURNER, M
    BROWN, A
    KISSONERGHIS, AM
    GADNELL, M
    GRAY, PW
    CHERNAJOVSKY, Y
    FELDMANN, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 223 (03): : 831 - 840
  • [8] Declercq W, 1998, J IMMUNOL, V161, P390
  • [9] The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
    Degli-Esposti, MA
    Dougall, WC
    Smolak, PJ
    Waugh, JY
    Smith, CA
    Goodwin, RG
    [J]. IMMUNITY, 1997, 7 (06) : 813 - 820
  • [10] Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
    DegliEsposti, MA
    Smolak, PJ
    Walczak, H
    Waugh, J
    Huang, CP
    DuBose, RF
    Goodwin, RG
    Smith, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 1165 - 1170